Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer

Published:2018-01 Issue:1 Volume:26 Page:45-55
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Liu Lina,Wang Yuhua,Miao Lei,Liu Qi,Musetti Sara,Li Jun,Huang Leaf

Funder

NIH

State Scholarship Fund of China Scholarship Council

Science and Technology Foundation of Guizhou Province

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference51 articles.

1. High efficacy of a Listeria-based vaccine against metastatic breast cancer reveals a dual mode of action;Kim;Cancer Res.,2009

2. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California Cancer Registry;Bauer;Cancer,2007

3. A review of triple-negative breast cancer;Ismail-Khan;Cancer Contr.,2010

4. Cripto-1 as a novel therapeutic target for triple negative breast cancer;Castro;Oncotarget,2015

5. Cancer vaccines: between the idea and the reality;Finn;Nat. Rev. Immunol.,2003

Cited by 277 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated immunogenomic analysis of single-cell and bulk profiling reveals novel tumor antigens and subtype-specific therapeutic agents in lung adenocarcinoma;Computational and Structural Biotechnology Journal;2024-12

2. A recent perspective on designing tumor vaccines for tumor immunology;International Immunopharmacology;2024-12

3. Core-shell tecto dendrimers co-deliver drug/gene for immunomodulation of macrophages and dendritic cells and checkpoint blockade-promoted breast cancer chemoimmunotherapy;Nano Today;2024-10

4. mRNA vaccines in tumor targeted therapy: mechanism, clinical application, and development trends;Biomarker Research;2024-08-31

5. The current therapeutic cancer vaccines landscape in non‐small cell lung cancer;International Journal of Cancer;2024-08-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3